Clinical Trial

REal World MAIA UK OutcomEs

Name: REal World MAIA UK OutcomEs — clinical trial record (NCT07532473)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: REMAKE

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study will describe the use of triplet therapy with daratumumab, lenalidomide and dexamethasone (DRd) in the treatment of for transplant ineligible (TIE) untreated myeloma outside of clinical trials and assess the associated clinical outcomes.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-04-08.

Trial Details

NCT Number	NCT07532473
Lead Sponsor	The Royal Wolverhampton Hospitals NHS Trust Collaborators: Johnson & Johnson
Conditions	Myeloma
Enrollment	300 participants
Start Date	2026-07
Primary Completion	2028-07 (estimated)
Study Completion	2028-07 (estimated)
Updated on ClinicalTrials.gov	2026-04-20